Morphine Sulfate Suppository shortage
To Be Discontinued 4 presentations · 1 manufacturers · first FDA posting 2026-07-23 · last update 2026-07-23
Manufacturers: Padagis US LLC
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Morphine Sulfate, Suppository, 5 mg (NDC 0574-7110-12) | Padagis US LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 07/23/2026 Updated 07/23/2026 Discontinued 07/23/2026 |
| Morphine Sulfate, Suppository, 10 mg (NDC 0574-7112-12) | Padagis US LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 07/23/2026 Updated 07/23/2026 Discontinued 07/23/2026 |
| Morphine Sulfate, Suppository, 20 mg (NDC 0574-7114-12) | Padagis US LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 07/23/2026 Updated 07/23/2026 Discontinued 07/23/2026 |
| Morphine Sulfate, Suppository, 30 mg (NDC 0574-7116-12) | Padagis US LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 07/23/2026 Updated 07/23/2026 Discontinued 07/23/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)